Sign Up to like & get
recommendations!
2
Published in 2022 at "Pediatrics"
DOI: 10.1542/peds.2022-057634
Abstract: There are limited data on vaccine effectiveness (VE) against the Omicron variant in adolescents. In Ontario, Canada, most vaccinated adolescents completed their primary series of BNT162b2 during summer 2021; third dose eligibility (6 months following…
read more here.
Keywords:
effectiveness bnt162b2;
vaccine effectiveness;
omicron;
bnt162b2 delta ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Pediatrics"
DOI: 10.1542/peds.2022-060894
Abstract: OBJECTIVES We assessed BNT162b2 vaccine effectiveness (VE) against mild to moderate and severe coronavirus disease 2019 (COVID-19) in children and adolescents through the Omicron BA.4/BA.5 period. METHODS Using VISION Network records from April 2021 to…
read more here.
Keywords:
bnt162b2 covid;
effectiveness bnt162b2;
waning 150;
150 days ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Epidemiologia e prevenzione"
DOI: 10.19191/ep22.4.a513.065
Abstract: OBJECTIVES to evaluate immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers (HCWs). DESIGN cohort study. SETTING AND PARTICIPANTS in a hospital in Milan (Lombardy Region, Northern Italy) HCWs without ("negative…
read more here.
Keywords:
effectiveness bnt162b2;
vaccination;
immunogenicity effectiveness;
effectiveness ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Polish archives of internal medicine"
DOI: 10.20452/pamw.16453
Abstract: INTRODUCTION The development of COVID-19 vaccines was the turning point of the ongoing pandemic. The Aim of this study is to describe the course of vaccination programme in Poland and effectiveness of BNT162b2 vaccine. OBJECTIVE…
read more here.
Keywords:
bnt162b2 vaccine;
effectiveness bnt162b2;
bnt162b2;
vaccination ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2022 at "Emerging infectious diseases"
DOI: 10.3201/eid2805.220141
Abstract: We estimated vaccine effectiveness (VE) of the BNT162b2 (Pfizer-BioNTech, https://www.pfizer.com) booster dose against SARS-CoV-2 infection and reduction of complications (hospitalization, severe disease, and death) among breakthrough cases in persons in Israel >16 years of age…
read more here.
Keywords:
cov infection;
sars cov;
breakthrough complications;
booster ... See more keywords